Pharmaq Analytiq Limited

ActiveSC267850 Private limited company
Incorporated
13 May 2004 (22 years)
Previously known as
FVG Limited (until 4 May 2021)
This list may be incomplete. See all names on Companies House
Industry
Veterinary activities (75000)
Directors
Nils Arne Grønlie
Trine Vatle
Owned by
Zoetis Inc
Accounts type
Small
Region
Scotland
Address
An Lochran
10 Inverness Campus
Inverness
IV2 5NA

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
19 December 2026
Last conf. stmt
5 December 2025

Charges

Total
9
Outstanding
0
Part satisfied
0
Satisfied
9

Officers 3 active

Officer details are public data from the Companies House register.

Grønlie, Nils Arne
Director · Appointed 1 July 2020
Norwegian
Born November 1967
Director · Appointed 1 July 2020
British
Born September 1976 (50)
Vatle, Trine
Director · Appointed 1 July 2020
Norwegian
Born June 1977 (49)
Officer history (17 former)
1 July 2020
Resigned Tonini, Hernan Rinaldo Pizarro as Director
1 July 2020
Appointed Vatle, Trine as Director
1 July 2020
Appointed Grønlie, Nils Arne as Director
1 July 2020
Resigned Prism Cosec Limited as Corporate Secretary
1 July 2020
Resigned Marshall, John William as Director
1 July 2020
Resigned Matthews, Christopher Graham Goodall as Director
1 July 2020
Appointed North, Benjamin Paul, Dr as Director
20 December 2019
Resigned Plampin, Mark James as Director
30 November 2019
Resigned Pye, Malcolm David Foster as Director
30 September 2019
Resigned Bonney, Roland James as Director
28 September 2018
Resigned Rodger, Hamish David Macleod as Director
20 August 2018
Appointed Prism Cosec Limited as Corporate Secretary
20 August 2018
Resigned David Venus & Company LLP as Corporate Secretary
31 May 2017
Resigned Layton, Ruth as Director
16 March 2016
Appointed Matthews, Christopher Graham Goodall as Director
5 June 2015
Resigned Prism Cosec Limited as Corporate Secretary
5 June 2015
Appointed David Venus & Company LLP as Corporate Secretary
4 June 2015
Resigned Southgate, Peter John as Director
2 December 2014
Resigned Cox, David Ivor as Director
11 February 2014
Appointed Prism Cosec Limited as Corporate Secretary
11 February 2014
Appointed Tonini, Hernan Rinaldo Pizarro as Director
11 February 2014
Resigned Endeavour Secretary Limited as Corporate Secretary
29 January 2014
Appointed Rodger, Hamish David Macleod as Director
5 January 2012
Resigned Wall, Anthony as Director
5 April 2011
Appointed Marshall, John William as Director
11 March 2010
Appointed Bonney, Roland James as Director
11 March 2010
Appointed Plampin, Mark James as Director
30 June 2004
Appointed Pye, Malcolm David Foster as Director
30 June 2004
Resigned Wall, Anthony as Secretary
30 June 2004
Appointed Layton, Ruth as Director
30 June 2004
Appointed Endeavour Secretary Limited as Corporate Secretary
13 May 2004
Appointed Oswalds Of Edinburgh Limited as Corporate Nominee Secretary
13 May 2004
Resigned Oswalds Of Edinburgh Limited as Corporate Nominee Secretary
13 May 2004
Appointed Wall, Anthony as Secretary
13 May 2004
Appointed Wall, Anthony as Director
13 May 2004
Appointed Cox, David Ivor as Director
13 May 2004
Appointed Southgate, Peter John as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Zoetis Inc
Corporate entity · Notified 1 July 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporate
Reg. no. 5118663
Former controllers (2)
1 July 2020
Ceased Pharmaq As — Owns 75–100% of shares
1 July 2020
Ceased Benchmark Animal Health Group Limited — Owns 75–100% of shares

Financials

Net Assets
£3,990,404
Cash
£913,464
Turnover
£2,124,105
Profit Before Tax
(£5,721,996)
Employees
19
Debt Ratio
10%
Current Ratio
9.1x
Profit Margin
-269%
Return on Equity
-143%

Trend

Turnover
£0 £5.0M £10.0M 2020 2021 2022 £7,283,410 £2,465,151 £2,124,105
Balance sheet detail
202220212020
Fixed Assets£602,081£5,388,476£9,960,200
Current Assets£3,808,946£5,088,189£991,163
Debtors£2,895,482£4,248,277£511,656
Cash£913,464£831,211£471,906
Creditors (< 1 year)£420,623£520,632£3,685,140
Creditors (> 1 year)£0£0
Net Current Assets£3,388,323£4,567,557(£2,693,977)
Net Assets£3,990,404£9,956,033£7,266,223
Shareholder Funds£3,990,404£9,956,033£7,266,223

Turnover£2,124,105£2,465,151£7,283,410
Cost of Sales£693,168£1,825,018£6,343,359
Gross Profit£1,430,937£640,133£940,051
Admin Expenses£7,195,879£927,937£1,601,405
Operating Profit(£5,752,909)£2,695,335(£661,354)
Profit Before Tax(£5,721,996)£2,695,305(£41,437)
Tax£5,495£14,933
Profit for Period(£5,721,996)£2,689,810(£56,370)

What Pharmaq Analytiq say about themselves

“PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health”

— from pharmaq.co.uk

Filings

Filing history not loaded yet. See it on Companies House

Some other companies at this address

Other companies in this industry

By trade and location

New Veterinary Practices →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?